EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of 3-week Sugen5416/hypoxia mice model?

Ruixuan Zheng, Tingting Xu, Ya Lin, Xiaoying Huang iD

Cardiovascular Research · 2023

DOI: 10.1093/cvr/cvad074 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Cardiovascular Research, 2023. Verfasst von Ruixuan Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Joint Centre of Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University Wenzhou, 1 Fanhai West Road, Ouhai District, Wenz…. Hauptthemen laut MEDLINE: Hypertension, Pulmonary. Die Arbeit nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We were intrigued by the article ‘Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension’ by Rodor et al.1 The study provided a fresh perspective on the subpopulations of endothelial cells (ECs) involved in pulmonary arterial hypertension (PAH) and garnered attention for its evidence of proliferation and mesenchymal transition processes.1 Previous studies have extensively examined the classic phenotypes of ECs in PAH, including injury and apoptosis at the early stage and proliferation at the late stage accompanied by pathological vascular remodeling.2 Since the cell cycle phase of ECs did not significantly change in PAH mice, Rodor et al. suggested that the number of proliferating ECs was not increased after 3 weeks of Sugen5416/hypoxia (SuHx) treatment. However, gene ontology (GO) analysis of differentially expressed genes (DEGs) between control and PAH groups revealed numerous proliferation-related items, such as regulation of angiogenesis (GO:0045765), regulation of vasculature development (GO:1901342), and endothelial cell proliferation (GO:0001935). We also compared the expression levels of representative EC proliferation genes, such as bone morphogenetic protein receptor type 2,3 caveolin 1/2,4 and secreted protein acidic and cysteine rich,5 and found that they were upregulated in ECs from PAH mice, indicating a higher tendency for EC proliferation (Figure 1A). (A) DEGs of endothelial cell proliferation (GO:0001935). Control group vs. SuHx group: three control groups, respectively, include 4935, 3429, and 3209 cells, and three SuHx groups, respectively, include 5127, 5805, and 2997 cells. (B) Expression level of ACTA2 in CDH5(+) and PECAM(+) cells. Three control groups, respectively, include 1875, 2020, and 1056 CDH5(+) and PECAM(+) cells and three IH groups, respectively, include 3084, 2075, and 2104 CDH5(+) and PECAM(+) cells. Significant difference tested by FindMarkers function of Seurat, Wilcox method was used for differential expression analysis, and both min.pct and logfc.threshold were set as 0.2. (C) Expression proportion of ACTA2 in CDH5(+) and PECAM(+) cells. Control group vs. IH group: three control groups, respectively, include 478, 607, and 183 ACTA2(+) cells and three IH groups, respectively, include 819, 697, and 434 ACTA2(+) cells. Not significant test by unpaired t-test (P = 0.55). (D) Representative images of immunofluorescence double-stained of PECAM and ACTA2 in lung cryo-sections from mice under normoxia and three-week SuHx. Another notable characteristic of ECs in PAH is endothelial-to-mesenchymal transition. In pathological conditions, ECs gradually lose the expression of endothelial markers such as Cadherin 5 (CDH5) and platelet and endothelial cell adhesion molecule (PECAM) and switch to expressing mesenchymal markers like actin alpha 2 (ACTA2) and collagen type I alpha 1 chain.6 Rodor et al. suggested that only a very low number of ECs expressed mesenchymal markers in control groups (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryMiceAnimalsEndothelial CellsHypoxiaCell ProliferationEpithelial-Mesenchymal TransitionCell Hypoxia

Autor:innen und Institutionen

  • Joint Centre of Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University Wenzhou, 1 Fanhai West Road, Ouhai District, Wenzhou City, Zhejiang Province 325000, China.
  • Division of Pulmonary Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 1 Fanhai West Road, Ouhai District, Wenzhou City, Zhejiang Province 325000, China.
  • Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, Wenzhou, 1 Fanhai West Road, Ouhai District, Wenzhou City, Zhejiang Province 325000, China.

ORCID-Profile: Xiaoying Huang

Zitieren

APA

Zheng, R., Xu, T., Lin, Y., & Huang, X. (2023). Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of 3-week Sugen5416/hypoxia mice model?. Cardiovascular Research. https://doi.org/10.1093/cvr/cvad074

Vancouver

Zheng R, Xu T, Lin Y, Huang X. Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of 3-week Sugen5416/hypoxia mice model?. Cardiovascular Research. 2023. doi:10.1093/cvr/cvad074

BibTeX
@article{Zheng2023,
  author = {Zheng, Ruixuan and Xu, Tingting and Lin, Ya and Huang, Xiaoying},
  title = {Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of 3-week Sugen5416/hypoxia mice model?},
  journal = {Cardiovascular Research},
  year = {2023},
  doi = {10.1093/cvr/cvad074}
}
Kostenlos starten →